Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Treat index level as a practical tool to guide trades, enabling more consistent setups and disciplined execution across markets.
20,888 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A DTCC update effective March 2, 2026 unlocks post-trade routing of institutional volumes to the XRP Ledger, as Rippl...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Coinbase and MicroStrategy’s Strategy stock both fell as investors trimmed exposure to digital asset names amid profi...
A rival’s blowout earnings stirred optimism across hardware names. This piece breaks down why super micro computer st...
A seasoned Mission Produce director just bought a substantial block of shares, signaling confidence in AVO. This arti...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...
For years, SK Hynix has traded at a discount to Micron. This article explains why the gap exists, what could close it...
Friday brought a notable rally for Integer Holdings as earnings beat and optimistic analyst updates boosted sentiment...
Gas prices across the U.S. rose by 11 cents per gallon, according to AAA, dampening consumer budgets as crude markets...
Insider stock moves can be routine or signaling. This article breaks down the facts behind ford's farley sells 6,454,...
Nvidia stock sank today as investors weighed growth, margins, and AI demand ahead of next week’s earnings. This guide...